OLANZAPINE TEVA ® 15 MG

Χώρα: Ισραήλ

Γλώσσα: Αγγλικά

Πηγή: Ministry of Health

Δραστική ουσία:

OLANZAPINE 15 MG

Διαθέσιμο από:

SALOMON,LEVIN & ELSTEIN LTD

Φαρμακολογική κατηγορία (ATC):

N05AH03

Φαρμακοτεχνική μορφή:

FILM COATED TABLETS

Οδός χορήγησης:

PER OS

Κατασκευάζεται από:

TEVA OPERATIONS POLAND SP.ZO.O

Θεραπευτική ομάδα:

OLANZAPINE

Θεραπευτικές ενδείξεις:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Ημερομηνία της άδειας:

2011-04-01